Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process

Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses "streamlining" the FDA's drug approval process as it relates to the 21st Century Cures Act.

Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.

In a 344-77 vote this morning, the U.S. House of Representatives voted overwhelmingly to approve the 21st Century Cures Act.

Related Content:

CURE TV
‘Incredible’ That a One-Time Infusion of CAR-T Cell Therapy Induces Durable Responses in Acute Lymphoblastic Leukemia
Why It’s Important to Be a Well-Educated, Proactive Patient
Immunotherapy Could 'Provide A Whole New Realm' For Patients with Myeloma